| 產品名稱 |
Rotavirus A |
| 商品貨號 |
B217830 |
| Classification |
Reoviridae, Rotavirus, Rotavirus A |
| Deposited As |
Human rotavirus |
| Agent |
Rotavirus A |
| Strain |
WI61 |
| Applications |
Enteric Research |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation |
human infant, Philadelphia, PA |
| Product Format |
frozen |
| Storage Conditions |
-70°C or colder |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Comments |
may cause gastroenteritis in infants -20C to -70C Propagate in cells fed with serum-free medium containing 0.5 ug/ml purified trypsin. |
| Effect on Host |
Yes, in vitro effects: Cytopathic effects (rounding and detachment of cells, plaque formation) in MA-104 cells with massive cell destruction in 5 to 6 days CPE, massive cell destruction |
| Recommended Host |
MA-104 cells (ATCC CRL-2378) Recommended Host: MA-104 cells (ATCC? CRL-2378.1?) MA-104 cells (ATCC CRL-2378); CV-1 cells (ATCC CCL-70) |
| Growth Conditions |
Atmosphere: 5% CO2 in air recommended Temperature: 36.0°C Duration: 1-4 days at 36C |
| Cryopreservation |
Storage temperature: -70 C or colder |
| Name of Depositor |
Children's Hospital of Philadelphia, Wistar Institute of Anatomy and Biology |
| U.S. Patent |
|
| U.S. Patent Number |
|
| Special Collection |
NCRR Contract |
| Source |
human infant, Philadelphia, PA |
| References |
Clark HF, et al. Rotavirus reassortant vaccine. US Patent 5,626,851 dated May 6 1997
|
